ENTITY
Aurobindo Pharma

Aurobindo Pharma (ARBP IN)

104
Analysis
Health CareIndia
Aurobindo Pharma Limited manufactures and markets oral and sterile antibiotics, antibacterials, anti-ulcerants and other generic basic drugs. Products include semi-synthetic penicillin drugs like ampicillin and amoxycillinas well as antibiotics, which include cloxacillin and dicloxacillin. The Company also manufactures formulations like astemizole, domeperidone and omeprazole.
more
21 Jul 2022 10:20

NIFTY100 Index Rebalance Preview: Couple of Changes in August, Then 5 More in September

There are two index changes at the close on 5 August, then there should be 5 more at the close on 29 September. Passive funds will have over 4-5...

Logo
540 Views
Share
16 May 2022 10:15

NIFTY100 Index Rebalance Preview: Five Potential Changes in September

We see five potential changes to the NIFTY100 Index at the September rebalance. Most are high probability changes and there will be over 1.5 days...

Logo
445 Views
Share
15 May 2022 18:17

Aurobindo Pharma (ARBP IN): Regulatory Issues Continue to Haunt the Company

Aurobindo's U.S. business is under continued pressure and fresh regulatory issue regarding its oral manufacturing facility further delays the...

Logo
316 Views
Share
30 Mar 2022 19:20

Aurobindo-Veritaz Acquisition: No Justice

Negative net-worth and continuous loss making nature, coupled with large debt size does not do justice to the valuation. The fact that Veritaz is a...

Logo
270 Views
Share
30 Mar 2022 08:21

NIFTY Index Rebalance: Flows at the Close Today

The March rebalance for the NIFTY family of indices will be implemented at the close of trading today. There is a fair amount to trade on the adds,...

Logo
381 Views
Share
x